Finance

Lists
KROS:NASDAQ
Keros Therapeutics Inc
10,65 $
+6,55%
(+0,65) 1D
10,65 $
0,00% (0,00)
After hours
Closed: 6 օգս, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KROS...
Open
9,97 $
High
10,71 $
Low
9,97 $
Mkt. cap
211,27 մլն
Avg. vol.
0,00
Volume
386,63 հզր
52-wk high
22,55 $
52-wk low
9,69 $
EPS
-3,70 $
Beta
0,99
Shares outstanding
19,83 մլն
No. of employees
92
Open
9,97 $
High
10,71 $
Low
9,97 $
Mkt. cap
211,27 մլն
Avg. vol.
0,00
Volume
386,63 հզր
52-wk high
22,55 $
52-wk low
9,69 $
EPS
-3,70 $
Beta
0,99
Shares outstanding
19,83 մլն
No. of employees
92
News stories
From sources across the web
About Keros Therapeutics Inc
CEO-
Employees92
Founded2015
HeadquartersLexington, Մասսաչուսեթս, Միացյալ Նահանգներ
Sector-
Websitekerostx.com
Analyst ratings
Based on 8 analysts giving stock ratings to KROS in the past 3 months
Buy
Buy
4
Hold
4
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for KROS in the last 3 months.
Highest
Current 10,65 $
23,00 $ (+115,96%)
Average
19,40 $ (+82,16%)
Lowest
16,00 $ (+50,23%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yun Zhong
Wedbush
Hold
Maintained
16,00 $
+50,2%
08/04/2026
Benjamin Burnett
Wells Fargo
Buy
Reiterated
18,00 $
+69%
08/03/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
20,00 $
+87,8%
08/04/2026
Matt Phipps
William Blair
Hold
Maintained
-
-
08/04/2026
Thomas Smith
Leerink Partners
Buy
Maintained
23,00 $
+116%
08/04/2026
Nicholas Lorusso
TD Cowen
Hold
Reiterated
-
-
08/04/2026
Jason Zemansky
Bank of America Securities
Hold
Reiterated
20,00 $
+87,8%
06/03/2026
Srikripa Devarakonda
Truist Financial
Buy
Maintained
-
-
05/15/2026
Andreas Argyrides
Oppenheimer
Buy
Maintained
27,00 $
+153,5%
03/09/2026
Unknown Analyst
Leerink Partners
Buy
Reiterated
30,00 $
+181,7%
03/06/2026
Tiago Fauth
Raymond James
Buy
Maintained
20,00 $
+87,8%
03/05/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
Revenue
18,17 մլն
14,26 մլն
385,00 հզր
367,00 հզր
Cost of goods sold
43,50 մլն
19,52 մլն
17,81 մլն
16,10 մլն
Cost of revenue
43,50 մլն
19,52 մլն
17,81 մլն
16,10 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14,48 մլն
10,13 մլն
11,74 մլն
10,15 մլն
Operating expense
14,48 մլն
10,13 մլն
11,74 մլն
10,15 մլն
Total operating expenses
57,98 մլն
29,65 մլն
29,56 մլն
26,24 մլն
Operating income
-39,82 մլն
-15,38 մլն
-29,17 մլն
-25,88 մլն
Other non operating income
-
-
-539,00 հզր
-
EBT including unusual items
-32,92 մլն
-8,70 մլն
-24,98 մլն
-23,71 մլն
EBT excluding unusual items
-32,92 մլն
-8,70 մլն
-24,88 մլն
-23,71 մլն
Income tax expense
-2,22 մլն
-1,42 մլն
-1,51 մլն
-
Effective tax rate
6,75%
16,36%
6,06%
-
Other operating expenses
-
-
-
-
Net income
-30,70 մլն
-7,28 մլն
-23,46 մլն
-23,71 մլն
Net profit margin
-168,96%
-51,04%
-6 093,77%
-6 459,95%
Earnings per share
-0,76
-0,18
-0,86
-1,21
Interest and investment income
7,12 մլն
6,93 մլն
4,02 մլն
2,34 մլն
Interest expense
-
-
-
-
Net interest expenses
7,12 մլն
6,93 մլն
4,02 մլն
2,34 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-39,45 մլն
-14,99 մլն
-28,77 մլն
-25,47 մլն
Gain or loss from assets sale
-14,00 հզր
-
1,00 հզր
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps